RGEDF (Chemical Works of Gedeon Richter) Forward PE Ratio: 8.39 (As of Jul. 11, 2026)


RGEDF Chemical Works of Gedeon Richter PLC RGEDF
94 GF Score
Price $39.18
GF Value $35.26
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Chemical Works of Gedeon Richter Forward PE Ratio?

Chemical Works of Gedeon Richter RGEDF +3.18% 94 Forward PE Ratio is 8.39 as of Jul. 11, 2026. GuruFocus rates RGEDF with a GF Score™ of 94/100 and a GF Value™ of $35.26 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 409 Drug Manufacturers companies, Chemical Works of Gedeon Richter ranks better than 85.09% on this metric.

Chemical Works of Gedeon Richter's Forward PE Ratio for today is 8.39.

Chemical Works of Gedeon Richter's PE Ratio without NRI for today is 17.01.

Chemical Works of Gedeon Richter's PE Ratio (TTM) for today is 18.43.


Chemical Works of Gedeon Richter  (OTCPK:RGEDF) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Chemical Works of Gedeon Richter Forward PE Ratio Related Terms


Chemical Works of Gedeon Richter Forward PE Ratio Historical Data

* Premium members only.

The historical data trend for Chemical Works of Gedeon Richter's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chemical Works of Gedeon Richter Forward PE Ratio Chart

Chemical Works of Gedeon Richter Annual Data
Trend 2022-12 2023-12 2024-12 2025-12
Forward PE Ratio
5.49 6.14 7.12 6.44

Chemical Works of Gedeon Richter Quarterly Data
2022-12 2023-06 2023-09 2023-12 2024-03 2024-06 2024-12 2025-03 2025-06 2025-12
Forward PE Ratio 5.49 7.66 6.90 6.14 7.39 6.75 7.12 6.87 6.42 6.44

RGEDF vs ZTS, UTHR, VTRS: Forward PE Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Chemical Works of Gedeon Richter's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chemical Works of Gedeon Richter Forward PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chemical Works of Gedeon Richter's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Chemical Works of Gedeon Richter's Forward PE Ratio falls into.


RGEDF
94GF Score
Chemical Works of Gedeon Richter PLC RGEDF
Forward PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chemical Works of Gedeon Richter Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Frequently Asked Questions Learn more about Forward PE Ratio →
What does a Forward PE Ratio of 8.39 mean?
Chemical Works of Gedeon Richter (RGEDF) has a Forward PE Ratio of 8.39 as of Jul. 11, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Chemical Works of Gedeon Richter and its competitors. According to the industry distribution chart, Chemical Works of Gedeon Richter ranks #61 out of 409 companies in the Drug Manufacturers industry, placing it in the top 14.9%.
Is Chemical Works of Gedeon Richter's Forward PE Ratio too high?
Chemical Works of Gedeon Richter's current Forward PE Ratio is 8.39. The Drug Manufacturers industry median Forward PE Ratio is 17.36. Chemical Works of Gedeon Richter's value of 8.39 is 51.7% below this industry median. Based on the distribution chart, Chemical Works of Gedeon Richter ranks #61 out of 409 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Chemical Works of Gedeon Richter has a GF Score™ of 94/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Chemical Works of Gedeon Richter's Forward PE Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Chemical Works of Gedeon Richter ranks #61 out of 409 companies for Forward PE Ratio. This places Chemical Works of Gedeon Richter in the top 15% of its industry — outperforming the majority of peers. The industry median Forward PE Ratio is 17.36. Chemical Works of Gedeon Richter's value of 8.39 is 51.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Drug Manufacturers company?
The median Forward PE Ratio among Drug Manufacturers companies is 17.36, based on 409 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chemical Works of Gedeon Richter's current Forward PE Ratio of 8.39 is 51.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Chemical Works of Gedeon Richter and its competitors. For the Drug Manufacturers industry, the median Forward PE Ratio is 17.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chemical Works of Gedeon Richter's current Forward PE Ratio is 8.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemical Works of Gedeon Richter stock overvalued right now?
Based on GuruFocus' analysis, Chemical Works of Gedeon Richter (RGEDF) is currently considered Modestly Overvalued. The stock's GF Value™ is $35.26, compared to a current price of $39.18 — trading 11.1% above its estimated fair value. The current Forward PE Ratio is 8.39 and 51.7% below the Drug Manufacturers industry median of 17.36. Chemical Works of Gedeon Richter's overall GF Score™ is 94/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Chemical Works of Gedeon Richter (RGEDF), the current Forward PE Ratio is 8.39 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chemical Works of Gedeon Richter (RGEDF) Overvalued in 2026?

Based on GuruFocus' analysis, Chemical Works of Gedeon Richter stock appears to be overvalued. The current stock price of $39.18 is trading 11.1% above its estimated GF Value™ of $35.26. GuruFocus considers Chemical Works of Gedeon Richter to be Modestly Overvalued.

Key valuation signals for RGEDF:

  • Forward PE Ratio: 8.39
  • GF Value™: $35.26 vs. price of $39.18 (11.1% above fair value)
  • GF Score™: 94/100 with 5 warning signs
  • Industry Position: 51.7% below the Drug Manufacturers median (#61 of 409)

No single metric tells the full story. See the RGEDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Chemical Works of Gedeon Richter Business Description

Address Gyomroi ut 19-21, Budapest, HUN, 1103
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular, and central nervous system products. It manufactures medicines including original, generic and licensed products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharma segment comprising Women's Healthcare, Neuropsychiatry, Biotechnology, General Medicine, and Other pharma; and the Others segment includes the remaining wholesale and retail business of the Group and all other activities. The company operates internationally.
94GF Score

Get the complete analysis for RGEDF

Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$39.18
Price
$35.26
GF Value